Overexpression of FAM198B increases the risk of drug resistance against cisplatin, topotecan, and paclitaxel and suppresses the proliferation and migration of ovarian cancer cell lines, suggesting a potential role in the treatment of ovarian cancer (90–92). This evidence concerns the gene GASK1B and ovarian cancer.